Solid Biosciences (SLDB) Capital Leases (2018 - 2024)
Historic Capital Leases for Solid Biosciences (SLDB) over the last 7 years, with Q3 2024 value amounting to $307000.0.
- Solid Biosciences' Capital Leases fell 7745.96% to $307000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $307000.0, marking a year-over-year decrease of 7745.96%. This contributed to the annual value of $1.2 million for FY2023, which is 2753.96% down from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Capital Leases is $307000.0, which was down 7745.96% from $953000.0 recorded in Q2 2024.
- Over the past 5 years, Solid Biosciences' Capital Leases peaked at $1.7 million during Q4 2022, and registered a low of $231000.0 during Q1 2022.
- For the 5-year period, Solid Biosciences' Capital Leases averaged around $818470.6, with its median value being $632000.0 (2020).
- As far as peak fluctuations go, Solid Biosciences' Capital Leases skyrocketed by 59090.91% in 2023, and later plummeted by 7745.96% in 2024.
- Quarter analysis of 5 years shows Solid Biosciences' Capital Leases stood at $525000.0 in 2020, then plummeted by 44.19% to $293000.0 in 2021, then skyrocketed by 481.23% to $1.7 million in 2022, then fell by 27.54% to $1.2 million in 2023, then tumbled by 75.12% to $307000.0 in 2024.
- Its Capital Leases was $307000.0 in Q3 2024, compared to $953000.0 in Q2 2024 and $1.1 million in Q1 2024.